PT87162B - Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos - Google Patents

Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos Download PDF

Info

Publication number
PT87162B
PT87162B PT87162A PT8716288A PT87162B PT 87162 B PT87162 B PT 87162B PT 87162 A PT87162 A PT 87162A PT 8716288 A PT8716288 A PT 8716288A PT 87162 B PT87162 B PT 87162B
Authority
PT
Portugal
Prior art keywords
compound
acid
group
pyrid
formula
Prior art date
Application number
PT87162A
Other languages
English (en)
Portuguese (pt)
Other versions
PT87162A (pt
Inventor
David Gwyn Cooper
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT87162A publication Critical patent/PT87162A/pt
Publication of PT87162B publication Critical patent/PT87162B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PT87162A 1987-04-07 1988-04-05 Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos PT87162B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878708233A GB8708233D0 (en) 1987-04-07 1987-04-07 Pharmaceutically active compounds

Publications (2)

Publication Number Publication Date
PT87162A PT87162A (pt) 1988-05-01
PT87162B true PT87162B (pt) 1992-07-31

Family

ID=10615351

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87162A PT87162B (pt) 1987-04-07 1988-04-05 Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos

Country Status (13)

Country Link
US (1) US4902698A (el)
EP (1) EP0287270B1 (el)
JP (1) JPS63267760A (el)
AT (1) ATE84028T1 (el)
AU (1) AU598654B2 (el)
CA (1) CA1330343C (el)
DE (1) DE3877036T2 (el)
DK (1) DK189988A (el)
ES (1) ES2052711T3 (el)
GB (1) GB8708233D0 (el)
GR (1) GR3007089T3 (el)
PT (1) PT87162B (el)
ZA (1) ZA882374B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
DE4037112A1 (de) * 1990-11-22 1992-05-27 Thomae Gmbh Dr K Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5286736A (en) * 1990-11-22 1994-02-15 Dr. Karl Thomae Gmbh Pyridyl compounds and pharmaceutical compositions containing these compounds
RU2163598C2 (ru) * 1994-12-20 2001-02-27 Ф.Хоффманн-Ля Рош Аг Производные арил- и гетероарилсульфонамидов и фармацевтическая композиция на их основе
US6653331B2 (en) * 1996-07-03 2003-11-25 Pharmacia & Upjohn Company Targeted drug delivery using sulfonamide derivatives
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054338A (el) * 1963-07-11
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4210759A (en) * 1978-05-24 1980-07-01 Henkel Corporation Benzene sulfonamido pyridine derivatives
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
CA1278577C (en) * 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
GB8528398D0 (en) * 1985-11-19 1985-12-24 Glaxo Group Ltd Chemical compounds
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3629929A1 (de) * 1986-09-03 1988-03-10 Thomae Gmbh Dr K Neue sulfonamido-aethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GR3007089T3 (el) 1993-07-30
DE3877036T2 (de) 1993-05-19
ES2052711T3 (es) 1994-07-16
AU598654B2 (en) 1990-06-28
DK189988A (da) 1988-10-08
CA1330343C (en) 1994-06-21
PT87162A (pt) 1988-05-01
EP0287270B1 (en) 1992-12-30
DK189988D0 (da) 1988-04-07
EP0287270A1 (en) 1988-10-19
ATE84028T1 (de) 1993-01-15
ZA882374B (en) 1989-03-29
US4902698A (en) 1990-02-20
JPS63267760A (ja) 1988-11-04
GB8708233D0 (en) 1987-05-13
AU1406888A (en) 1988-10-13
DE3877036D1 (de) 1993-02-11

Similar Documents

Publication Publication Date Title
EP0365183B1 (en) Biologically active compounds
Cain et al. Potential antitumor agents. 16. 4'-(Acridin-9-ylamino) methanesulfonanilides
CZ381192A3 (en) Imidazole derivatives with side biphenylsulfonylurea or biphenylsulfonylurethane chain, process for preparing said derivatives and a pharmaceutical composition in which said derivatives are comprised
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
JPH0253762A (ja) 新規スルホンアミドおよびこれを含有する、物質代謝機能病および血行障害治療薬
EP0239907B1 (de) Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
PT87162B (pt) Processo de preparacao de composto do acido piridilalcanoico contendo um grupo sulfonamido e de composicoes farmaceuticas contendo tais compostos
PL184320B1 (pl) Nowe związki, pochodne 4-sulfonylo-lub 4-sulfinylobenzoiloguanidyny, sposób ich wytwarzania oraz preparat farmaceutyczny
DE3850308T2 (de) Tetrahydroisochinolin-2-yl-Derivate als Thromboxan A2-Antagonisten.
JP2707936B2 (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
EP0136737B1 (en) 1-(4'alkylsulfonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives
US5576327A (en) Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
PL180872B1 (pl) Nowe związki, pochodne arylobenzoiloguanidyny, sposób ich wytwarzania oraz preparat farmaceutyczny
US4127574A (en) 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
US4124587A (en) 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
US4912135A (en) Amide compounds
US5280043A (en) Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US4097528A (en) N-(2-diphenylmethoxyethyl)-N-(1-methyl-2-phenoxyethyl)-N-methyl! amine
US3953493A (en) Substituted sulfonamide derivatives as anthelmintic agents
US3991188A (en) 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions
JPH03284669A (ja) 4―フェニルフタラジン誘導体
US5646310A (en) N-(2-cyanoethyl)-6-fluoroalkyl-2h-1-benzopyran derivatives
JPH0399080A (ja) ピラゾロピリジン誘導体
JPS643874B2 (el)
DE102004043937A1 (de) Ortho-substituierte Pentafluorsulfuranyl-Benzole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Synthese-Zwischenstufen

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920128